The human T-cell leukemia virus type 1 (HTLV-1), identified as the first human oncogenic
retrovirus 30 years ago, is not an ubiquitous virus. HTLV-1 is present throughout the world …

The African continent is considered the largest high endemic area for the oncogenic
retrovirus HTLV-1 with an estimated two to five million infected individuals. However, data on …

Blood safety remains an important public health concern in Africa where lack of availability
or provision of unsafe blood adversely impacts morbidity and mortality in the region. In …

The high prevalence of numerous endemic and epidemic diseases such as malaria, HIV
infection and viral hepatitis in some areas of sub‐Saharan Africa (SSA) affects the health …

Although the World Health Organization (WHO) has set targets for safe blood by 2012, Sub‐
Saharan Africa remains confronted with multi‐factorial issues that compromise blood safety …

Human T cell leukemia virus (HTLV-1) is an oncoretrovirus that infects at least 10 million
people worldwide. HTLV-1 exhibits a remarkable genetic stability, however, viral strains …

Infectious risk associated with blood transfusion remains a major public health challenge in
Africa, where prevalence rates of the major transfusion-transmissible infections (ie, hepatitis …

The description of the first human retrovirus, human T-lymphotropic virus 1 (HTLV-1), was
soon associated with an aggressive lymphoma and a chronic inflammatory …

Sexually transmitted infections (STIs) represent a worldwide public health problem and,
although many of them are curable, they continue to be neglected, especially in areas with a …

Objectives Human T‐lymphotropic virus (HTLV)‐1 causes T‐cell leukaemia and myelopathy.
Together with HTLV‐2, it is endemic in some African nations. Seroprevalence data from …